文献速递免疫规划妇幼与学校卫生

多模式干预提高妇产科疫苗接种率的效果

Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings.
PubMed 文献 · Vaccine · 2019-05-15

该整群随机对照试验在科罗拉多州9家私立妇产科诊所评估多模式干预对孕妇流感、百白破(Tdap)疫苗接种及非孕妇流感、Tdap、人乳头瘤病毒(HPV)疫苗接种的效果。结果显示干预组与对照组孕妇疫苗接种率均有改善,但非孕妇接种率始终很低(≤6%)。

要点

  • 多模式干预未显著提高孕妇流感疫苗接种率,干预组29% vs 对照组41%。
  • 孕妇Tdap接种率两组均升至51%,与推荐变更一致。
  • 非孕妇三种疫苗接种率均≤6%,干预效果有限。

核心结论

  • 多模式干预未能显著提高孕妇流感疫苗接种率,但两组孕妇Tdap接种率均大幅上升,非孕妇疫苗接种率始终很低。

研究设计与样本

  • 整群随机对照试验,纳入科罗拉多州9家私立妇产科诊所,研究期为2011年9月至2014年5月。
  • 干预措施包括指定免疫倡导者、员工/提供者培训、疫苗采购/管理协助、识别合格患者、实施常规医嘱、病历审查/反馈及患者教育材料;对照诊所维持常规护理。
  • 主要结局为孕妇流感及Tdap疫苗接种率、非孕妇流感/Tdap/HPV疫苗接种率,比较基线期(第0/1年)与第2年干预组与对照组差异。
  • 估算每组样本量32,590例,有>80%把握度检测组间10%差异。

主要发现

  • 基线期干预组与对照组孕妇流感疫苗接种率均为27%;第2年干预组为29%,对照组为41%。
  • 基线期干预组孕妇Tdap接种率为18%,对照组为22%;第2年两组均升至51%,干预组增加33%,对照组增加29%。
  • 研究期间任一时点,干预组和对照组非孕妇患者接种HPV、流感或Tdap疫苗的比例均≤6%。

临床怎么用

  • 在妇产科诊所推行多模式干预时,需针对非孕妇人群设计更有效的免疫策略。
  • 孕妇Tdap接种率提升可能与推荐变更有关,干预措施应结合最新指南动态调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the effectiveness of a multimodal intervention in obstetrics/gynecology (ob-gyn) clinics to increase uptake of influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccines in pregnant women and these vaccines plus human papillomavirus (HPV) vaccine in non-pregnant women. METHODS: A cluster randomized controlled trial among 9 private ob-gyn practices in Colorado from 9/2011 to 5/2014. The intervention consisted of: designation of immunization champions, staff/provider trainings, assistance with vaccine purchasing/management, identification of eligible patients, standing order implementation, chart review/feedback, and patient education materials. Control practices continued usual care. Primary outcomes were receipt of influenza and Tdap vaccines among pregnant women and these vaccines plus HPV vaccine among non-pregnant women, comparing a Baseline period (Year 0/Year 1) to Year 2, intervention versus control. With an estimated sample size of 32,590 per arm, there would be >80% power to detect a 10% difference between groups. RESULTS: In the Baseline period, 27% of pregnant women in both intervention and control practices received influenza vaccine. In Year 2, 29% of pregnant women in intervention practices received influenza vaccine versus 41% in control practices. In the Baseline period, 18% of pregnant women in intervention practices received Tdap vaccine versus 22% in control practices. Both intervention and control practices increased to 51% in Year 2, representing an increase of 33% for intervention practices and 29% for control practices, consistent with a change in Tdap recommendations. Relatively few HPV, influenza or Tdap vaccines (≤6% of eligible patients) were given to non-pregnant patients in either intervention or control practices at any time during the study. CONCLUSION: In this cluster randomized trial designed to increase vaccination uptake, both intervention and control practices showed improved vaccination of pregnant but not non-pregnant patients. Future work should focus on tailoring evidence-based immunization practices or developing new approaches to specifically fit busy ob-gyn offices.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. O'Leary ST, Pyrzanowski J, Brewer SE, et al. Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings. Vaccine. 2019. PMID: 31103367. doi:10.1016/j.vaccine.2019.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。